DME With Substantial Claims Denials Subject To Prior Authorization - HCFA
This article was originally published in The Gray Sheet
Durable medical equipment (DME) that has had a "substantial" number of claims denied should be among the items subject to prior authorization, the Health Care Financing Administration says in a March 20 proposed rule.
You may also be interested in...
Sandoz announced more than a year ago that its GP2411 biosimilar denosumab candidate had entered the clinic. Management provided an update on its progress at the recent Virtual Meet Novartis Management Investor Event.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.